Revo Biologics, Inc. Company Profile
✉ Email this page to a colleague
Biologic Drugs for Revo Biologics, Inc.
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Revo Biologics, Inc. | ATRYN | antithrombin (recombinant) | For Injection | 125284 | 5,843,705 | 2015-02-21 | DrugPatentWatch analysis and company disclosures |
| Revo Biologics, Inc. | ATRYN | antithrombin (recombinant) | For Injection | 125284 | 6,432,657 | 2018-07-22 | DrugPatentWatch analysis and company disclosures |
| Revo Biologics, Inc. | ATRYN | antithrombin (recombinant) | For Injection | 125284 | 6,500,992 | 2020-11-09 | DrugPatentWatch analysis and company disclosures |
| Revo Biologics, Inc. | ATRYN | antithrombin (recombinant) | For Injection | 125284 | 6,632,978 | 2020-10-20 | DrugPatentWatch analysis and company disclosures |
| Revo Biologics, Inc. | ATRYN | antithrombin (recombinant) | For Injection | 125284 | 6,784,347 | 2021-01-12 | DrugPatentWatch analysis and company disclosures |
| Revo Biologics, Inc. | ATRYN | antithrombin (recombinant) | For Injection | 125284 | 7,001,740 | 2022-07-29 | DrugPatentWatch analysis and company disclosures |
| Revo Biologics, Inc. | ATRYN | antithrombin (recombinant) | For Injection | 125284 | 7,041,872 | 2022-05-31 | DrugPatentWatch analysis and company disclosures |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
